Aquestive Therapeutics, Inc.
AQST
$6.54
-$0.15-2.24%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -13.55M | -22.93M | -17.06M | -11.51M | -2.75M |
| Total Depreciation and Amortization | 140.00K | 139.00K | 170.00K | 159.00K | 205.00K |
| Total Amortization of Deferred Charges | 2.75M | 2.75M | 2.70M | 2.67M | 2.67M |
| Total Other Non-Cash Items | 1.83M | 1.63M | 2.41M | 1.63M | 1.23M |
| Change in Net Operating Assets | 919.00K | -4.99M | 5.28M | -4.83M | -8.36M |
| Cash from Operations | -7.91M | -23.40M | -6.49M | -11.88M | -7.01M |
| Capital Expenditure | -107.00K | -135.00K | -15.00K | -80.00K | -35.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -107.00K | -135.00K | -15.00K | -80.00K | -35.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -8.00K | -6.00K | -5.00K | -8.00K | -5.00K |
| Issuance of Common Stock | -- | 21.36M | 168.00K | 193.00K | 1.72M |
| Repurchase of Common Stock | -86.00K | -703.00K | -1.00K | -202.00K | -5.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -6.00K | -5.00K | -5.00K | -- | -- |
| Cash from Financing | -100.00K | 20.65M | 157.00K | -17.00K | 1.71M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.12M | -2.89M | -6.35M | -11.98M | -5.33M |